JVL medic
ActiveSummary
JVL medic has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €382,939 and a net result of €381,939. Equity is growing by about 5.4% per year across the filed financial years. Its solvency ranks better than 90% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
12-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2020 to 2025net €381,939 ▲10.7%
Operating result €519,857, net result €381,939, both a record.
17-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Liquidity more than 17 timescurrent ratio 18.46
Current ratio from 1.07 to 18.46; short-term debt falls from €412,287 to €20,575.
31-12
Financial
Equity above €200,000equity €388,197 ▲801%
A profit in every financial year since 2020 builds equity to €388,197.
15-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
06-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Equity above €500,000equity €608,649 ▲84.1%
A profit in every financial year since 2020 builds equity to €608,649.
19-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial
Equity above €200,000equity €330,671 ▲309%
A profit in every financial year since 2020 builds equity to €330,671.
28-09
NBB filing
Annual accounts filed
financial year 2020 · micro format · 59 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.